Systemic thromboses after cardiopulmonary bypass: is it thrombin or antithrombin?
Tanaka
Kenichi A
KA
Sniecinski
Roman
R
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D000991:Antithrombins / Q000502:physiology*; D007611:Aprotinin / Q000627:therapeutic use*; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D004351:Drug Resistance; D006490:Hemostatics / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011183:Postoperative Complications / Q000209:etiology*; D013917:Thrombin / Q000502:physiology*; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology*
D000925:Anticoagulants; D000991:Antithrombins; D006490:Hemostatics; D006493:Heparin; D007611:Aprotinin; D013917:Thrombin